o NoneEntity Type
0001549084
PN Med Group Inc.
PN Med Group Inc
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 EKSO BIONICS HOLDINGS, INC.
Jurisdiction of Incorporation/OrganizationNEVADA 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 EKSO BIONICS HOLDINGS, INC. 
Street Address 1Street Address 2
 1414 HARBOUR WAY SOUTH SUITE 1201
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 RICHMOND CALIFORNIA 94804 510-984-1761 



3. Related Persons
Last NameFirst NameMiddle Name
PeurachJack
Street Address 1Street Address 2
1414 Harbour Way SouthSuite 1201
CityState/Province/CountryZIP/Postal Code
RichmondCALIFORNIA94804
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 principal executive officer

Last NameFirst NameMiddle Name
ShermanSteven
Street Address 1Street Address 2
1414 Harbour Way SouthSuite 1201
CityState/Province/CountryZIP/Postal Code
RichmondCALIFORNIA94804
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
GlennJohnF.
Street Address 1Street Address 2
1414 Harbour Way SouthSuite 1201
CityState/Province/CountryZIP/Postal Code
RichmondCALIFORNIA94804
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 principal financial and accounting officer

Last NameFirst NameMiddle Name
HamiltonMarilyn
Street Address 1Street Address 2
1414 Harbour Way SouthSuite 1201
CityState/Province/CountryZIP/Postal Code
RichmondCALIFORNIA94804
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
LiCharles
Street Address 1Street Address 2
1414 Harbour Way SouthSuite 1201
CityState/Province/CountryZIP/Postal Code
RichmondCALIFORNIA94804
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
SternStanley
Street Address 1Street Address 2
1414 Harbour Way SouthSuite 1201
CityState/Province/CountryZIP/Postal Code
RichmondCALIFORNIA94804
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
WangTed
Street Address 1Street Address 2
1414 Harbour Way SouthSuite 1201
CityState/Province/CountryZIP/Postal Code
RichmondCALIFORNIA94804
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
SchreckThomas
Street Address 1Street Address 2
1414 Harbour Way SouthSuite 1201
CityState/Province/CountryZIP/Postal Code
RichmondCALIFORNIA94804
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
JonesJason
Street Address 1Street Address 2
1414 Harbour Way SouthSuite 1201
CityState/Province/CountryZIP/Postal Code
RichmondCALIFORNIA94804
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
ShawWilliam
Street Address 1Street Address 2
1414 Harbour Way SouthSuite 1201
CityState/Province/CountryZIP/Postal Code
RichmondCALIFORNIA94804
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   x Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  o Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2021-02-11 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests o Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
  
(Associated) Broker or Dealer o None(Associated) Broker or Dealer CRD Number o None
  
Street Address 1Street Address 2
  
City State/Province/CountryZIP/Postal Code
   
State(s) of Solicitation o All States
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 3499990 USD o Indefinite
Total Amount Sold $ 0 USD 
Total Remaining to be Sold $ 3499990 USD o Indefinite
 
Clarification of Response (if Necessary)
  


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 4


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 0 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Ekso Bionics Charts.
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Ekso Bionics Charts.

Ekso Bionics Holdings, Inc. News

Ekso Bionics Announces First Quarter 2024 Financial Results
Tuesday 30 April 2024 (4 days ago) • GlobeNewswire Inc.
Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024
Monday 22 April 2024 (2 weeks ago) • GlobeNewswire Inc.
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal
Friday 12 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Ekso Bionics Reports Record Annual Revenue of $18.3 Million
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.
Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Wednesday 17 January 2024 (4 months ago) • Edgar (US Regulatory)
Ekso Bionics Announces $4.6 Million Registered Direct Offering
Friday 12 January 2024 (4 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Thursday 11 January 2024 (4 months ago) • Edgar (US Regulatory)
Ekso Bionics Launches GaitCoach Software for EksoNR
Tuesday 9 January 2024 (4 months ago) • GlobeNewswire Inc.
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results
Friday 5 January 2024 (4 months ago) • GlobeNewswire Inc.

More Ekso Bionics Holdings, Inc. News Articles